Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anticoagulation Treatment”

879 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 879 results

Testing effectiveness (Phase 2)Study completedNCT00911300
What this trial is testing

Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm

Who this might be right for
Fibrillation, Atrial
GlaxoSmithKline 349
Not applicableLooking for participantsNCT03504007
What this trial is testing

Registry of Patients Prescribed Anticoagulation

Who this might be right for
Acute Deep Vein ThrombosisAcute Pulmonary Embolism
Mayo Clinic 10,000
Post-approval studies (Phase 4)UnknownNCT05671276
What this trial is testing

Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage Occlusion

Who this might be right for
Atrial FibrillationLeft Atrial Appendage OcclusionSilent Cerebral Embolism
The First Affiliated Hospital with Nanjing Medical University 150
Not applicableUnknownNCT03976440
What this trial is testing

Simplified Regional Citrate Anticoagulation Protocols for CVVH, CVVHDF and SLED: a Pilot Study

Who this might be right for
Acute Renal FailureDialysis Related ComplicationHypophosphatemia+1 more
University of Parma 30
Not applicableUnknownNCT05133713
What this trial is testing

Ventilation and Perfusion Scan in Pulmonary Embolism Following Catheter Directed Thrombectomy Versus Anticoagulation Alone

Who this might be right for
Pulmonary EmbolismPulmonary HypertensionChronic Thromboembolic Pulmonary Hypertension
University of Arizona 50
Not applicableStudy completedNCT02858518
What this trial is testing

Risk of Bleeding and Anticoagulation in Atrial Fibrillation: What Predictive Criterion Used?

Who this might be right for
Atrial FibrillationGerontology
Centre Hospitalier Universitaire de Saint Etienne 120
Not applicableStudy completedNCT02447341
What this trial is testing

Profile and Antithrombotic Management of Patients With NVAF Attending Internal Medicine Departments in Spain (PERFILAR Study)

Who this might be right for
Anticoagulation, Blood Thinners , Atrial Fibrillation, Bleeding, Stroke
Bristol-Myers Squibb 987
Post-approval studies (Phase 4)Study completedNCT03895502
What this trial is testing

Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study

Who this might be right for
Venous ThrombosisNeoplasmsAnticoagulant
Takeshi Morimoto 605
Not applicableUnknownNCT00669721
What this trial is testing

OPG and RANKL Plasma Level After Administration of Unfractionated Heparin (UFH) and Low-Molecular-Weight Heparin (LMWH) in Hemodialysis

Who this might be right for
Renal FailureHemodialysis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 40
Post-approval studies (Phase 4)Study completedNCT02247414
What this trial is testing

Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection

Who this might be right for
CirrhosisHypertensionStatus;Splenectomy+1 more
Yangzhou University 124
Not applicableLooking for participantsNCT03642509
What this trial is testing

Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation

Who this might be right for
Atrial FibrillationStroke
University of Aarhus 750
Testing effectiveness (Phase 2)Study completedNCT00436787
What this trial is testing

Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers

Who this might be right for
Venous ThrombosisPulmonary Embolism
University of Pittsburgh 21
Large-scale testing (Phase 3)Looking for participantsNCT03907046
What this trial is testing

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Who this might be right for
Intracerebral HemorrhageAtrial Fibrillation
Yale University 700
Large-scale testing (Phase 3)Looking for participantsNCT04284839
What this trial is testing

The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial

Who this might be right for
Bleeding Post Cardiac SurgeryIndication for Anticoagulation
Population Health Research Institute 3,500
Not applicableNot Yet RecruitingNCT07543393
What this trial is testing

Nudging for Anticoagulation Adherence in Atrial Fibrillation

Who this might be right for
Atrial Fibrillation (AF)
Sun Yat-sen University 84
Post-approval studies (Phase 4)Study completedNCT02247128
What this trial is testing

Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation

Who this might be right for
Aortic Valve DiseaseMyocardial InfarctionStroke+1 more
St. Antonius Hospital 1,016
Early research (Phase 1)Study completedNCT01826266
What this trial is testing

Effects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of Edoxaban

Who this might be right for
Anticoagulant ReversalReversal of Edoxaban Induced Anticoagulation
Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. 83
Not applicableStudy completedNCT00456001
What this trial is testing

Heparin Induced Thrombocytopenia: Pharmacoeconomics

Who this might be right for
Heparin Induced Thrombocytopenia (HIT)
Brigham and Women's Hospital 200
Not applicableUnknownNCT04527666
What this trial is testing

Anticoagulation in Gastroesophageal Varices and JAK2 Mutation

Who this might be right for
Gastroesophageal VaricesJAK2 MutationMyeloproliferative Neoplasm
Shanghai Zhongshan Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00116012
What this trial is testing

Anticoagulation With rNAPc2 to Eliminate MACE/TIMI 32

Who this might be right for
Coronary Disease
ARCA Biopharma, Inc. 300
Next Page